Moderna, Inc. · Biotechnology

MRNAModerna, Inc.

Reports 2026-11-06 Pre-market · FriReaction day 11-06upcoming

Before the print · expectations15 days to the print

Street consensus

−$1.29EPS
$903MRevenue

No past prints on file yet.

What the record doesn't tell you

Which way does MRNA go on 11‑06?

  • Model lean for 11-06, and the evidence behind it
  • Move band, P10 – P90
  • Last 8 prints, quarter by quarter
  • Peers that already reported, and how they traded
Start 30-day free trialFull access · no card requiredHave an account? Sign inThe lean freezes the night before the print.

The print · 8-K and callupcoming · 2026-11-06 · Pre-market

Revenue—
est. $903M
EPS—
est. −$1.29
Guidance—read from the 8-K once filed

Lean, stance and evidence on this page are model outputs, not investment advice. Trade at your own risk. Disclaimer →

Moderna earnings preview: what the record says

Moderna (MRNA) is scheduled to report earnings on Nov 6, 2026, before the open. The consensus estimate calls for EPS of −$1.29 on revenue of $903M.

NextPick tracks MRNA in its Biotech basket alongside VRTX, REGN, BIIB and ALNY, whose prints read through to this one.

Figures come from NextPick's earnings-reaction ledger and the options market. Not investment advice.

MRNA earnings: key questions

When is MRNA's next earnings date?

Moderna is scheduled to report on Nov 6, 2026, before the open.

What are MRNA's earnings expectations?

Analysts expect EPS of −$1.29 on revenue of $903M for the quarter.